Skip to content
Newsroom

$4M Funding Furthers Belluscura’s U.S. Expansion Goals

Sallyport Commercial Finance is delighted to announce a $4,000,000 funding facility for Belluscura, a trailblazing medical device company focused on developing innovative oxygen enrichment technology. The funding, comprising accounts receivable and cash flow loans, will empower Belluscura to expand its operations into the U.S. market, supporting the production and distribution of their groundbreaking oxygen treatment devices.

Belluscura is on a mission to improve health outcomes for patients with Chronic Obstructive Pulmonary Disease (COPD) and other respiratory conditions. Their enriched oxygen treatment platforms are designed to enhance patient care while delivering favorable economic outcomes for healthcare providers and insurance companies. By innovating rapidly and navigating regulatory pathways efficiently, Belluscura aims to reduce treatment costs, increase available options and deliver value to patients.

The strategic move to secure funding from Sallyport comes at a critical time for Belluscura, as they prepare for the formal launch of their device in 2025 following a successful soft launch. This financial boost will enable the company to scale production and capitalize on growing demand in the business-to-business market.

Nick Hart, President of Sallyport Commercial Finance, shared his excitement about the partnership:

“Sallyport is proud to fuel innovation and growth for companies like Belluscura. This funding underscores our commitment to empowering businesses to deliver life-enhancing solutions, such as their groundbreaking oxygen devices, to a global market.”

This partnership highlights Sallyport’s unique ability to support UK-owned subsidiaries operating in North America, where other lenders often hesitate. By working closely with Cadence Advisory, Sallyport was able to provide the financial resources Belluscura needs to achieve its ambitious goals.

Belluscura’s dedication to improving healthcare outcomes and reducing treatment costs aligns perfectly with Sallyport’s mission to empower businesses to thrive and achieve a meaningful impact in their industries.

For more information on how Sallyport can support your business growth, reach out to us today!

Posted in
  • News

$500K Facility Drives Tire Distributor Expansion

July 20, 2026

Growing businesses often need access to flexible working capital to take advantage of opportunities when they arise. For one tire…

Read More

$5M Facility Powers Kitchen Cutlery Brand Growth

July 16, 2026

Sallyport Commercial Finance is delighted to announce the successful funding of a $5,000,000 combined Accounts Receivable and Inventory Finance facility…

Read More
  • Articles

us-manufacturing-blog-image

Is US Manufacturing the Route to Economic Recovery?

There’s a big sea change underway in US manufacturing, the start of which predates the significant economic and political events…

Read More

How to Choose an Invoice Factoring Company

You’ve already done your research and invoice factoring seems to be the most suitable option for financing your business. Other…

Read More
  • Videos

The Most Financial Time of the Year

Sallyport commercial finance’s Annual Holiday Music Video!  

View Now

Supporting Businesses in 2020

View Now
Scroll To Top